Movers and Shakers Rally Hard While Others Crash Today

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  03 Nov 2025
 

•   ALVO  
   
  -0.20%
•   AMKR  
   
  -0.32%
•   CURR  
   
  -6.69%
•   FMFC  
   
  +11.22%
•   MD  
   
  +2.38%

$RAY dominated the gainers list with a stunning 31.94% jump to $0.22, propelled by an extraordinary volume spike to 140.89 million shares versus its typical 1.04 million average. The massive rally came as Lucas GC announced first-half 2025 financial results showing earnings per share of $1.47 on revenue of $54.008 million, figures that clearly exceeded market expectations and triggered aggressive buying interest.

$MSAI carved out an impressive 26.92% gain to reach $1.98, extending its winning streak to five consecutive days of advances. Volume exploded to 60.70 million shares compared to its 18.87 million average, suggesting institutional accumulation driving the sustained upward momentum.

$MD posted a solid 24.11% advance to $21.08 as Pediatrix Medical Group delivered its third-quarter 2025 earnings report. Trading volume jumped to 2.14 million shares, more than triple its typical average, reflecting heightened investor interest in the company's quarterly performance.

$VVPR surged 18.64% to $3.50 on news that VivoPower has formed a strategic partnership with Kweather that will provide exposure to XRP. The announcement generated significant buzz among both crypto enthusiasts and traditional equity traders, driving volume to 1.30 million shares versus its normal baseline.

$AMKR climbed 17.22% to $37.84 despite technical indicators showing the stock has entered overbought territory. Volume reached 9.12 million shares against a 2.91 million average, indicating strong institutional participation as the semiconductor packaging provider benefits from broader chip sector optimism.

On the downside,
$ZOOZ suffered a brutal 46.81% collapse to $0.75, extending its losing streak to six consecutive down days despite announcing a $50 million share repurchase program. The buyback authorization failed to stem the selling pressure, with volume swelling to 10.91 million shares, suggesting deeper concerns about the company's fundamentals.

$CURR plunged 37.30% to $2.37 after revealing it has entered into a non-binding term sheet with Animoca Brands regarding a potential reverse merger proposal. Volume exploded to 31.11 million shares as shareholders viewed the proposed transaction unfavorably, perhaps due to concerns about dilution or valuation.

$ALVO experienced a devastating 34.25% decline to $5.03 following the FDA's Complete Response Letter declining to approve AVT05, the company's biosimilar version of Simponi. Compounding the negative sentiment, management also cut its EBITDA outlook, prompting a rush to exit positions as volume surged to 4.35 million shares.

$YYAI dropped 24.56% to $1.72, marking its fifth consecutive day of losses as the sustained selling pressure without apparent news suggests either sector rotation or technical breakdown triggering momentum selling.

$FMFC rounded out the notable losers with a 21.01% decline to $1.09, also extending its losing streak to five straight sessions on volume that exceeded its typical average.

View All Headlines